GSK
North America, Pennsylvania, United States, Kelayres
Description
GSK is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.
Investor Profile
GSK has backed more than 18 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 11% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Switzerland.
- Strong thematic focus on Health Care, Biotechnology, Pharmaceutical.
Stage Focus
- Series A (28%)
- Series B (22%)
- Series C (22%)
- Post Ipo Equity (11%)
- Series E (6%)
- Seed (6%)
- Series Unknown (6%)
Country Focus
- United States (72%)
- United Kingdom (11%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Switzerland (6%)
- Canada (6%)
- Sweden (6%)
Industry Focus
- Health Care
- Biotechnology
- Pharmaceutical
- Therapeutics
- Medical
- Life Science
- Clinical Trials
- Health Diagnostics
- Oncology
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does GSK frequently co-invest with?
Which angels does GSK often collaborate with?
What are some of recent deals done by GSK?
Find More Investors Like GSK
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
